Skip to main content
SpringerLink
Log in

Viscosupplementation for the Treatment of Osteoarthritis of the Knee with Hyaluronan and Hylans: Rationale and State of the Art

  • Conference paper
Advances in Osteoarthritis

Summary

Hyaluronan is essential in maintaining the homeostasis of joint tissues and synovial fluid through its elastoviscosity, lubricating properties, protection of cells and nerves, molecular sieving effect, and metabolic influence on synovial cells. These properties are molecular weight- and concentration dependent. In osteoarthritis (OA), synovial fluid hyaluronan becomes less effective because of dilution and a decrease in molecular weight. Through viscosupplementation, a therapeutic procedure of serial intra-articular injections of high molecular weight hyaluronan or its derivatives, hylans, the normal elastoviscous properties of synovial fluid may be restored. The reported tolerance of viscosupplementation is very good, with similar results for the three available products. Local adverse effects occur after approximately 2% of the injections in 2%-4% of the patients; these are typically short lived and have no sequelae. This efficacious and safe treatment is the only therapy for osteoarthritis that addresses the mechanorheological homeostasis of joint tissues.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 54.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Laurent TC (1987) Biochemistry of hyaluronan. Acta Otolaryngol Suppl 442:7–24

    Article  PubMed  CAS  Google Scholar 

  2. Laurent TC, Fraser RE (1992) Hyaluronan. FASEB J 6:2397–2404

    CAS  Google Scholar 

  3. Mikelsaar R, Scott JE (1994) Molecular modeling of secondary and tertiary structures of hyaluronan, compared with electron microscopy and NMR data. Possible sheet and tabular structures in aqueous solution. Glycoconj J 11:65–71

    Article  PubMed  CAS  Google Scholar 

  4. Ghosh P (1994) The role of hyaluronic acid (hyaluronan) in health and disease: interactions with cells, cartilage, and components of synovial fluid. Clin Exp Rheumatol 12:75–82

    PubMed  CAS  Google Scholar 

  5. Balazs EA, Gibbs DA (1970) The rheological properties and biological function of hyaluronic acid. In: Balazs EA (ed) Chemistry and molecular biology of the intercellular matrix. Academic, London, pp 1241–1254

    Google Scholar 

  6. Levick JR, McDonald JN (1990) Influence of intra-articular hyaluronan on flow across the synovial lining of knees in anesthetized rabbits. J Physiol (Camb) 422:23

    Google Scholar 

  7. Levick JR (1992) Synovial fluid. Determinants of volume turnover and material concentration. In: Kuettner K, Schleilrbach R, Peyron J, Hascall V (eds) Articular cartilage and osteoarthritis. Raven, New York, pp 529–541

    Google Scholar 

  8. Hadler NM, Napier MA (1977) Structure of hyaluronic acid in synovial fluid and its influence on the movement of solutes. Semin Arthritis Rheum 7:141–152

    Article  PubMed  CAS  Google Scholar 

  9. Paschalakis P, Vynios DH, Tsiganos CP, et al (1993) Effects of proteoglycans on hydroxyapatite growth in vitro: the role of hyaluronan. Biochim Biophys Acta 1158:129–136

    Article  PubMed  CAS  Google Scholar 

  10. Campion GV, Shellis RP, Dieppe PA (1990) The effect of synovial fluid and serum on the growth of calcium hydroxyapatite crystals. J Rheumatol 17:515–520

    PubMed  CAS  Google Scholar 

  11. Ogston AG, Stanier JE (1953) The physiological function of hyaluronic acid in synovial fluid: viscous, elastic, and lubricant properties. J Physiol (Camb) 115:244–252

    Google Scholar 

  12. Darzynkiewicz Z, Balazs EA (1971) Effect of connective tissue intercellular matrix on lymphocyte stimulation. I. Suppression of lymphocyte stimulation by hyaluronic acid. Exp Cell Res 66:113–123

    Article  PubMed  CAS  Google Scholar 

  13. Balazs EA, Darzynkiewicz Z (1973) The effect of hyaluronic acid on fibroblast, mononuclear phagocytes, and lymphocytes. In: Kuionen E, Pikkarainen J (eds) Biology of the fibroblast. Academic, London, pp 237–252

    Google Scholar 

  14. Forrester JV, Balazs EA (1980) Inhibition of phagocytosis by high molecular weight hyaluronate. Immunology 40:435–446

    PubMed  CAS  Google Scholar 

  15. Forrester JV, Wilkinson PC (1981) Inhibition of leukocyte locomotion by hyaluronic acid. J Cell Sci 48:315–331

    PubMed  CAS  Google Scholar 

  16. Brandt K (1970) Modification of chemotaction by synovial fluid hyaluronate. Arthritis Rheum 13:308

    Google Scholar 

  17. Piako EJ, Turner RA, Soderstrom LP, et al (1983) Inhibition of neutrophil phagocytosis and enzyme release by hyaluronic acid. Clin Exp Rheumatol 1:41–44

    Google Scholar 

  18. Larsen NE, Lombard KM, Parent EG, et al (1992) Effect of hylan on cartilage and chondrocyte culture. J Orthop Res 10:23–32

    Article  PubMed  CAS  Google Scholar 

  19. Yasui Y, Akatsuka M, Tobetto K, et al (1992) Effects of hyaluronan on the production of stromelysin and tissue inhibitor of metalloproteinase 1 (TIMP 1) in bovine articular chondrocytes. Agents Actions 37:155–156

    Article  PubMed  CAS  Google Scholar 

  20. Kikuchi T, Denda S, Yamaguchi T (1993) Effect of sodium hyaluronate (SL1010) on glycosaminoglycan synthesis and release in rabbit articular cartilage (in Japanese, summary in English). Jpn Pharmacol Ther 21(suppl 1):157–163

    Google Scholar 

  21. Smith MM, Ghosh P (1987) The synthesis of hyaluronic acid by human synovial fibroblasts is influenced by the nature of the hyaluronate in the extra cellular environment. Rheumatol Int 7:114–122

    Article  Google Scholar 

  22. Hammerman D, Wood DD (1984) Interleukins enhance synovial cell hyaluronate synthesis. Proc Soc Exp Biol Med 177:205–210

    Google Scholar 

  23. Konttinen YT, Saari H, Nordstrom DC (1991) Effect of interleukin 1 on hyaluronate synthesis by synovial fibroblastic cells. Clin Rheumatol 10:151–154

    Article  PubMed  CAS  Google Scholar 

  24. Balazs EA (1974) The physical properties of the synovial fluid and the special role of hyaluronic acid. In: Helfet A (ed) Disorders of the knee. Lippincott, Philadelphia, pp 63–75

    Google Scholar 

  25. Hiori K, Kikawa M, Takaichi K, et al (1993) Autoradiography of the knee joint after intra-articular administration of 14C sodium hyaluronate (14C-SL-1010) in rabbits (in Japanese, summary in English). Jpn Pharmacol Ther 21:201–206

    Google Scholar 

  26. Antonas KM, Fraser JRE, Muirden KD (1973) Distribution of biologically labeled hyaluronic acid injected into joints. Ann Rheum Dis 32:102–111

    Article  Google Scholar 

  27. Laurent UBG, Fraser RE, Engstrom-Laurent A, et al (1992) Catabolism of hyaluronan in the knee joint of the rabbit. Matrix 12:130–136

    PubMed  CAS  Google Scholar 

  28. Denlinger JL (1982) Metabolism of sodium hyaluronate in articular and ocular tissues. Ph.D. thesis, Université des Sciences et Techniques de Lille, Lille, France

    Google Scholar 

  29. Brown TJ, Laurent UBG, Fraser JRE (1991) Turnover of hyaluronan in synovial joints: ehmination of labeled hyaluronan from the knee joint of the rabbit. Exp Physiol 76:125–134

    PubMed  CAS  Google Scholar 

  30. Fraser JRE, Kimpton WG, Pierscionek BK, et al (1993) The kinetics of hyaluronan in normal and acutely inflamed synovial joints. Observations with experimental arthritis in sheep. Semin Arthritis Rheum 22(suppl 1):9–17

    Article  PubMed  CAS  Google Scholar 

  31. Sato I, Matsuo K, Akima K (1992) Studies on metabolic fate of sodium hyaluronate (SL1010) after intra-articular administration. Jpn Pharmacol Ther 21 (suppl 2):185–193

    Google Scholar 

  32. Balazs EA, Bloom GD, Swann DA (1966) Fine structure and glycosamino-glycan content of the surface layer of articular cartilage. Fed Proc 25:1813–1816

    PubMed  CAS  Google Scholar 

  33. Akima K, Matsuo K, Watari N, et al (1993) Studies on the metabolic fate of sodium hyaluronate after intra-articular administration (in Japanese, summary in English). Jpn Pharmacol Ther 21:173–183

    Google Scholar 

  34. Balazs EA, Watson D, Duff IF, et al (1967) Hyaluronic acid in synovial fluid, molecular parameters of hyaluronic acid in normal and arthritic human fluids. Arthritis Rheum 10:357–376

    Article  PubMed  CAS  Google Scholar 

  35. Saari H, Kontinen YT (1989) Determination of the concentration and polymerization of synovial fluid hyaluronate using high performance liquid chromatography. Ann Rheum Dis 48:565–570

    Article  PubMed  CAS  Google Scholar 

  36. Balazs EA, Briller S, Denlinger JL (1981) Na-hyaluronate molecular size variations in equine and arthritic synovial fluid and effect on phagocytic cells. Semin Arthritis Rheum 11:141–143

    Article  CAS  Google Scholar 

  37. Worall JG, Bayliss MT, Edwards JC (1990) Morphological localization of hyaluronan in normal and diseased synovium. J Rheum 18:1466–1472

    Google Scholar 

  38. Wells AF, Klareskog L, Lindblad S, et al (1992) Correlation between increased hyaluronan localized in arthritic synovium and the presence of proliferating cells. Arthritis Rheum 35:391–396

    Article  PubMed  CAS  Google Scholar 

  39. Pitsillides AA, Worall JG, Wilkinson LS, et al (1994) Hyaluronan concentration in non-inflamed and rheumatoid synovium. Br J Rheumatol 33:5–10

    Article  PubMed  CAS  Google Scholar 

  40. McDonald JN, Levick JR (1994) Hyaluronan reduces fluid escape from rabbit knee joints disparately from its effect on fluidity. Exp Physiol 79:103–106

    PubMed  CAS  Google Scholar 

  41. Levick JR (1996) Synovial fluid hydraulics. Sci Med 11:52–61

    Google Scholar 

  42. Mapp PI (1995) Innervations of the synovium. Ann Rheum Dis 54:398–403

    Article  PubMed  CAS  Google Scholar 

  43. Pozo A, Balazs EA, Belmonte C (1997) Reduction of sensory responses to passive movements of inflamed knee joints by hylan, a hyaluronan derivative. Exp Brain Res 116:3–9

    Article  PubMed  CAS  Google Scholar 

  44. Gotoh S, Onaya J, Abe M, et al (1993) Effects of the molecular weight of hyaluronic acid and its action mechanisms on experimental joint pain in rats. Ann Rheum Dis 52:817–822

    Article  PubMed  CAS  Google Scholar 

  45. Shimizu N, Matsui Y, Masaki F, et al (1993) Analgesic effect of high molecular weight sodium hyaluronate (SL 1010) on bradykinin-induced knee pain in beagles (in Japanese, summary in English). Jpn Pharmacol Ther 21:133–141

    Google Scholar 

  46. Maroudas A (1969) Studies on the formation of hyaluronic acid films. In: Wright V (ed) Lubrication and wear in joints. Sector, London, pp 124–133

    Google Scholar 

  47. Cooke AF, Dowson D, Wright V (1976) Lubrication of synovial membrane. Ann Rheum Dis 35:56–59

    Article  PubMed  CAS  Google Scholar 

  48. Radin EL, Paul JL (1972) A consolidated concept of joint lubrication. J Bone Joint Surg 54A:607–616

    Google Scholar 

  49. Swann DA, Radin EL, Nazimiec M, et al (1974) Role of hyaluronic acid in joint lubrication. Ann Rheum Dis 33:318–326

    Article  PubMed  CAS  Google Scholar 

  50. Jay GD, Lane BP, Sokoloff L (1992) Characterization of a bovine synovial fluid lubricating factor. III. The interaction with hyaluronic acid. Connect Tissue Res 28:245–255

    Article  PubMed  CAS  Google Scholar 

  51. Altman S, Zeidler H, Langer HE (1985) The frictional behavior of articular cartilage in relation to the lubricant (abstract). In: Transactions of the 15th symposium of the European Society of Osteoarthrology. University of Kuopio, Finland, p 525

    Google Scholar 

  52. Davies DY, Palfrey AJ (1968) Some of the physical properties of normal and pathological synovial fluid. J Biomech 1:79–88

    Article  PubMed  CAS  Google Scholar 

  53. Balazs EA, Denlinger JL (1984) The role of hyaluronic acid in arthritis and its therapeutic use in osteoarthritis. In: Peyron JG (ed) Current clinical and fundamental problems. Geigy, Paris, pp 165–174

    Google Scholar 

  54. Greenwald RA, Moy WW (1980) Effect of oxygen derived free radicals on hyaluronic acid. J Clin Invest 66:298–305

    Article  Google Scholar 

  55. Wright V, Dowson D, Unsworth A (1971) The role of lubrication in osteoarthrosis. In: Abstracts, VII European congress on rheumatology, Brighton. Arthritis and Rheumatism Council, London, 36:17

    Google Scholar 

  56. Martel-Pelletier J, Cloutier JM, Pelletier JP (1986) Neutral proteases in human osteoarthritic synovium. Arthritis Rheum 29:1112–1123

    Article  PubMed  CAS  Google Scholar 

  57. Westacott CI, Whicher JT, Barnes TC, et al (1990) Synovial fluid concentration of five different cytokines in rheumatic diseases. Ann Rheum Dis 49:676–681

    Article  PubMed  CAS  Google Scholar 

  58. Vignon E, Mathieu P, Conrozier T, et al (1990) Cytokines, phospholipase A2, prostaglandin E2 et metalloproteases du ciquide synovial dans la gonarthrose (abstract). Rev Rhum Mal Osteo Artie 57:682

    Google Scholar 

  59. Egg D (1984) Concentration of prostaglandin D2, E2, F(2), 6-keto-F (1), and thromboxane B2 in synovial fluid from patients with inflammatory disorders and osteoarthritis. J Rheumatol 43:89–96

    CAS  Google Scholar 

  60. Wittenberg RH, Willburger RE, Kleemeyerk S (1993) In vitro release of prostaglandins and leukotrienes from synovial tissue, cartilage, and bone in degenerative joint diseases. Arthritis Rheum 36:1444–1450

    Article  PubMed  CAS  Google Scholar 

  61. Gibilisco PA, Schumacher HR, Hollander JK, et al (1985) Synovial fluid crystals in osteoarthritis. Arthritis Rheum 28:511–515

    Article  PubMed  CAS  Google Scholar 

  62. Dieppe PA, Aiwan W (1987) Synovial fluid in osteoarthritis (abstract). Arthritis Rheum 30:S130

    Article  Google Scholar 

  63. Heinegard D, Inerot S, Wieslander O (1985) A method for the quantification of cartilage proteoglycan structures liberated to the synovial fluid during developing degenerative joint disease. Scand J Clin Invest 45:421–427

    PubMed  CAS  Google Scholar 

  64. Witter J, Roughley PJ, Webber C, et al (1987) The immunologic detection and characterization of cartilage proteoglycan degradation in synovial fluid of patients with arthritis. Arthritis Rheum 30:519–529

    Article  PubMed  CAS  Google Scholar 

  65. Shinmei M, Miyauchi S, Machida A, et al (1992) Quantitation of chondroitin 4-sulfate and chondroitin 6-sulfate in pathologic joint fluid. Arthritis Rheum 34:1304–1308

    Google Scholar 

  66. Obara T, Yamaguchi T, Moriya Y, et al (1993) Tissue distribution of fluorescein labeled sodium hyaluronate in experimentally induced osteoarthritis (in Japanese, summary in English). Jpn Pharmacol Ther 21:193–201

    Google Scholar 

  67. Greenwald RA (1991) Oxygen radicals, inflammation and arthritis: pathophysiological considerations and implication for treatment. Semin Arthritis Rheum 20:219–240

    Article  PubMed  CAS  Google Scholar 

  68. Schenck P, Schneider S, Miehlke R, et al (1995) Synthesis and degradation of hyaluronate by synovia from patients with rheumatoid arthritis. J Rheumatol 22:400–405

    PubMed  CAS  Google Scholar 

  69. Tobetto K, Yasui T, Ando T, et al (1992) Inhibitory effects of hyaluronan on 14C arachidonic acid release from labeled human synovial fibroblasts. Jpn J Pharmacol 60:79–84

    Article  PubMed  CAS  Google Scholar 

  70. Wigren A, Wik O, Falk J (1976) Intra-articular injection of high molecular weight hyaluronic acid. An experimental study on normal adult rabbit knee joints. Acta Orthop Scand 47:480–485

    Article  PubMed  CAS  Google Scholar 

  71. Abatangelo G, Botti P, Delbue M, et al (1989) Intra-articular sodium hyaluronate injections in the Pond-Nuki experimental model of osteoarthritis in dogs. Clin Orthop 241:278–285

    PubMed  Google Scholar 

  72. Schiavinato A, Lini E, Guidolin D, et al (1989) Intra-articular sodium hyaluronate injections in the Pond-Nuki experimental model of osteoarthritis in dogs. Clin Orthop 241:286–299

    PubMed  Google Scholar 

  73. Armstrong S, Read R, Ghosh P (1994) The effects of intra-articular hyaluronan on cartilage and subchondral bone changes in an ovine model of early osteoarthritis. J Rheumatol 21:680–688

    PubMed  CAS  Google Scholar 

  74. Yoshioka M, Shimizue C, Hardwood FL, et al (1997) The effect of hyaluronan during the development of osteoarthritis. Osteoarthritis Cartil 5:251–260

    Article  CAS  Google Scholar 

  75. Kikushi T, Yamagushi T, Sakakibard Y, et al (1993) Therapeutic effect of high molecular weight sodium hyaluronate (SL 1010) on the experimental osteoarthritis induced by rabbit knee immobilization (in Japanese, summary in English). Jpn Pharmacol Ther 21:123–131

    Google Scholar 

  76. Yoshimi T, Kikuchi T, Obaka T, et al (1994) Effects of high molecular weight sodium hyaluronate on experimental osteoarthrosis induced by the resolution of rabbit anterior cruciate ligament. Clin Orthop 298:296–304

    PubMed  Google Scholar 

  77. Toyoshima H (1978) The influence of synovectomy on articular cartilage of rabbit knee and preventive effects of hyaluronic acid on degenerative changes of the cartilage. J Tokyo Womens Med Coll 48:890

    Google Scholar 

  78. Kitoh Y, Katsurmaki T, Tanaka H, et al (1992) Effect of SL 1010 (sodium hyaluronate with high molecular weight) on experimental osteoarthritis induced by intra-articularly applied papain in rabbits (in Japanese, summary in English). Folia Pharmacol Jpn 100:67–76

    Article  CAS  Google Scholar 

  79. Kido H, Maeyama K, Tagawa T, et al (1993) Effect of high molecular weight sodium hyaluronate (SL 1010) on experimental osteoarthritis induced by immobilization of rabbit knee joint (in Japanese, summary in English). Jpn Pharmacol Ther 24:115–121

    Article  Google Scholar 

  80. Williams JM, Plaza V, Hui F, et al (1997) Hyaluronan suppresses fibronectin fragment mediated cartilage chondrolysis II in vivo. Osteoarthritis Cartil 5:235–240

    Article  CAS  Google Scholar 

  81. Asari A, Miyauchi S, Matsuzaka S, et al (1996) Hyaluronate on heat shock protein and synovial cells in a canine model of osteoarthritis. Osteoarthritis Cartil 4:213–215

    Article  CAS  Google Scholar 

  82. Balazs EA, Leshchiner EA (1989) Hyaluronan, its crosslinked derivative Hylan, and their medical applications. In: Inagaki H, Phillips GO (eds) Cellulosics utilization: research and rewards in cellulosics. Elsevier, New York, pp 233–241

    Google Scholar 

  83. Larsen NE, Lombard KM, Parent EG, Balazs EA (1992) Effect of hylan on cartilage and chondrocyte cultures. J Orthop Res 10:23–32

    Article  PubMed  CAS  Google Scholar 

  84. Al-Assaf S, Phillips GO, Deeble DJ, et al (1995) The enhanced stability of the cross-links hylan structure to hydroxyl (OH) radicals compared with the uncross-linked hyaluronan. Radiat Phys Chem 46:207–217

    Article  CAS  Google Scholar 

  85. Balazs EA, Denlinger JL (1985) Sodium hyaluronate and joint function. J Equine Vet Sci 5:217–228

    Article  Google Scholar 

  86. Philips MW (1989) Clinical trial comparison of intra-articular sodium hyaluronate products in the horse. J Equine Vet Sci 9:39–40

    Article  Google Scholar 

  87. Balazs EA, Denlinger JL (1993) Viscosupplementation. A new concept in the treatment of osteoarthritis. J Rheumatol 20(suppl 39):3–9

    Google Scholar 

  88. Balazs EA (ed) (1971) Hyaluronic acid and matrix implantation. Biotrics, Arlington, MA

    Google Scholar 

  89. Helfet J (1974) Management of osteoarthritis of the knee joint. In: Helfet J (ed) Disorders of the knee. Lippincott, Philadelphia, p 179

    Google Scholar 

  90. Peyron JG, Balazs EA (1974) Preliminary assessment of Na-hyaluronate injection into human arthritic joints. Pathol Biol 22:731–736

    PubMed  CAS  Google Scholar 

  91. Weiss C, Balazs EA, St. Onge R, et al (1981) Clinical studies of the intra-articular injection of Healon (sodium hyaluronate) in the treatment of osteoarthritis of i human knees. Semin Arthritis Rheum 11:143–144

    Article  Google Scholar 

  92. Namiki O, Toyoshima H, Morisaki N (1982) Therapeutic effect of intra-articular injection of high molecular weight hyaluronic acid on osteoarthritis of the knee. Int Clin Pharmacol Ther Toxicol 20:501–507

    CAS  Google Scholar 

  93. Oshima Y (1983) Intra-articular injection therapy of high molecular sodium hyaluronate on osteoarthritis of the knee joint. Phase II clinical study. Jpn Pharmacol Ther 11:2253–2257

    Google Scholar 

  94. Shichikawa AK and the drug evaluation committee of the Japanese Rheumatic Association (1983) Evaluation of the effect of sodium hyaluronate on osteoarthritis of the knee. Ryumachi 23:280–290

    Google Scholar 

  95. Honma T (1989) Clinical effect of high molecular weight sodium hyaluronate (Artz) injected into osteoarthritic knee joints. Jpn Pharmacol Ther 17:5057–5072

    Google Scholar 

  96. Igarashi M (1983) Multicenter clinical studies of high molecular weight sodium hyaluronate in the long-term treatment of osteoarthritis of the knee. Jpn Pharmacol Ther 11:4871–4888

    Google Scholar 

  97. Puhl W, Bernau A, Greiling H, et al (1993) Intra-articular sodium hyaluronate in osteoarthritis of the knee: a multicenter double-blind study. Osteoarthritis Cartil 1:219–232

    Article  Google Scholar 

  98. Dahlberg L, Lodhander LS, Ryd L (1994) Intra-articular injections of hyaluronan in patients with cartilage abnormalities and knee pain. A one-year double-blind, placebo-controlled study. Arthritis Rheum 37:521–528

    Article  PubMed  CAS  Google Scholar 

  99. Lohmander LS, Dalen N, Englund G, et al (1996) Intra-articular hyaluronan injections in the treatment of osteoarthritis of the knee. A randomized double-blind, placebo-controlled multicentre trial. Ann Rheum Dis 55:424–431

    Article  PubMed  CAS  Google Scholar 

  100. Bragantini A, Gassini M, Debastiani G, et al (1982) Controlled single blind trial of intra-articularly injected hyaluronic acid (Hyalgan) in osteoarthritis of the knee. Clin Trials J 24:333–340

    Google Scholar 

  101. Grecomoro G, Martorana J, Dimarco C (1987) Intra-articular treatment with sodium hyaluronate in gonarthrosis: a controlled clinical trial versus placebo. Pharmatherapeutica 5:137–141

    PubMed  CAS  Google Scholar 

  102. Carabba M, Paresce E, Angelin M, et al (1992) Efficacy and safety of different dose-schedules of intra-articular injections of hyaluronic acid in painful and hydarthrodial osteoarthritis of the knee. Results of a prospective randomized, placebo and arthrocentesis controlled study (abstract). In: Transactions of the VIIth Eular scientific symposium, London, pp 22–24

    Google Scholar 

  103. Henderson EB, Smith EC, Pegley F, et al (1994) Intra-articular injections of 750KD hyaluronan in the treatment of osteoarthritis: a randomized single center double-blind, placebo-controlled trial of 91 patients demonstrating lack of efficacy. Ann Rheum Dis 53:529–534

    Article  PubMed  CAS  Google Scholar 

  104. St. John Dixon A, Jacoby RK, Berry H, et al (1988) Clinical trials of intra-articular injections of sodium hyaluronate in patients with osteoarthritis of the knee. Curr Med Res Opin 11:205–213

    Article  PubMed  CAS  Google Scholar 

  105. Dougados M, Nguyen M, Listrat V, et al (1993) High molecular weight sodium hyaluronate (Hyalectin) in osteoarthritis of the knee. A one-year placebo-controlled trial. Osteoarthritis Cartil 1:97–104

    Article  CAS  Google Scholar 

  106. Listrat V, Ayral X, Patarnello F, et al (1997) Arthroscopic evaluation of potential structure modifying activity of hyaluronan (Hyalgan) in osteoarthritis of the knee. Osteoarthritis Cartil 5:153–160

    Article  CAS  Google Scholar 

  107. Pietrogrande V, Leonardi M, Ulivi M, et al (1989) Confronto clinico delia efficacia e tolerabilita del acido ialuronico e 6 metilprednisolone sommistrato per via intra-articolare nel trattamento della gonartrosi. Ortop Traum Oggi 9:275–280

    Google Scholar 

  108. Leardini G, Matara L, Franceschini M, et al (1991) Intra-articular treatment of knee osteoarthritis. A comparative study between hyaluronic acid and 6-methyl prednisolone acetate. Clin Exp Rheumatol 9:375–381

    PubMed  CAS  Google Scholar 

  109. Takigami S, Takigami M, Phillips GO (1993) Hydration characteristics of the cross-linked hyaluronan derivative hylan. Carbohydr Polym 22:153–160

    Article  CAS  Google Scholar 

  110. Scale D, Wobig M, Wolpert W (1994) Viscosupplementation of osteoarthritic knees with hylan-A treatment schedule study. Curr Ther Res 55:220–232

    Article  Google Scholar 

  111. Adams ME (1993) An analysis of clinical studies of the use of cross-linked hyaluronan, hylan, in the treatment of OA. J Rheum 20(suppl 39): 16–18.

    Google Scholar 

  112. Adams ME, Atkinson MH, Lussier A, et al (1995) The role of viscosupplementation with hylan G-F 20 (Synvisc) in the treatment of osteoarthritis of the knee. A Canadian multicenter trial comparing hylan G-F 20 alone, hylan G-F 20 with non-steroidal anti-inflammatory drugs (NSAIDs) and NSAIDs alone. Osteoarthritis Cartil 3:213–226

    Article  CAS  Google Scholar 

  113. Lussier A, Cividino AA, McFarlane CA, et al (1996) Viscosupplementation with hylan for the treatment of osteoarthritis: findings from clinical practice in Canada. J Rheumatol 23:1579–1585

    PubMed  CAS  Google Scholar 

  114. Adams ME (1997) Viscosupplementation with hylan vs. NSAID therapy: clinical trial experience. Osteoarthritis Cartil 5(suppl A):71

    Article  Google Scholar 

  115. Hollander JL, Jessar RA, Brown EM (1961) Intra-synovial corticosteroid therapy: a decade of use. Bull Rheuni Dis 11:239–240

    CAS  Google Scholar 

  116. Gray RG, Gottlieb NL (1983) Intra-articular corticosteroids. Clin Orthop 177:235–263

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Centre de Rhumathologie, Hôpital de la Pitié. 3 Rue des Dames Augustines, 92200 Neuilly sur Seine, 75013, Paris, France

    Jacques G. Peyron

Authors
  1. Jacques G. Peyron
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Kinki University School of Medicine, 377-2 Ohno-Higashi, Osaka-Sayama, 589-8511, Osaka, Japan

    Seisuke Tanaka M.D. (Dean) (Dean)

  2. Department of Orthopedic Surgery, Kinki University School of Medicine, 377-2 Ohno-Higashi, Osaka-Sayama, 589-8511, Osaka, Japan

    Chiaki Hamanishi M.D. (Professor) (Professor)

Rights and permissions

Reprints and permissions

Copyright information

© 1999 Springer-Verlag Tokyo

About this paper

Cite this paper

Peyron, J.G. (1999). Viscosupplementation for the Treatment of Osteoarthritis of the Knee with Hyaluronan and Hylans: Rationale and State of the Art. In: Tanaka, S., Hamanishi, C. (eds) Advances in Osteoarthritis. Springer, Tokyo. https://doi.org/10.1007/978-4-431-68497-8_17

Download citation

  • DOI: https://doi.org/10.1007/978-4-431-68497-8_17

  • Publisher Name: Springer, Tokyo

  • Print ISBN: 978-4-431-68499-2

  • Online ISBN: 978-4-431-68497-8

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation